fda glp-1 warning september 2025 news 15, 2025: Telehealth company must stop implying its compounded GLP -1 is FDA-approved, warns – Partnership for Safe Medicines Pharmacovigilance Assessment of Compounded GLP-1

The standard dose escalation begins at 2.5 mg subcutaneously once weekly for four weeks, followed by increases to 5 mg, 7.5 mg, 10 mg, 12.5 mg, and finally 15 mg at four-week intervals as tolerated

Some people feel like they have fully returned to their pre-medication state

The eye test isnt always accurate, but visual changes in your body are often a sign that youre making body composition changes

Expert advice becomes essential, not optional when dealing with them

Regarding renal health, the medication itself is not nephrotoxic, but the side effects (vomiting, diarrhea) can lead to dehydration, which may injure the kidneys